The U.S. Judiciary Panel on Multidistrict Litigation has consolidated nearly two dozen lawsuits in Louisiana federal court filed against Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer Corp., alleging the drug companies failed to warn that the blood thinner Xarelto could cause serious bleeding events. Defendants fought centralizing the lawsuits, claiming discrepancies in dosage and patients’ medical history made the cases too dissimilar. But the panel found the Xarelto side effects lawsuits struck a similar chord in their claims that the drug companies withheld information from clinical trials that showed the drug could increase the risk for life-threatening bleeding events. ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.